Supra Verma

Supra Verma, MD, is a Senior Medical Director at Amgen, a role they have held since 2023 following the Horizon acquisition. They previously served as a Medical Director at Adverum Biotechnologies, Inc. from 2017 to 2019 and held senior positions at Horizon from 2019 to 2023. Their earlier experience includes positions at Tufts University School of Medicine as a Physician, and at UCLA Health System as an MD and Clinical Researcher in the Division of Interventional Cardiology. Supra earned their Doctor of Medicine (MD) and a Bachelor of Arts from the University of California, where their education is ongoing.